Disease Resistance Screening

Disease Resistance Screening refers to the laboratory and field-based evaluation protocols used to identify cannabis plants with genetic or phenotypic resistance to pathogens, pests, and environmental stressors. Breeders employ screening methods—including controlled inoculation, molecular marker analysis, and grow trials under pathogenic pressure—to select parent plants that show reduced susceptibility to common threats such as powdery mildew, botrytis, spider mites, and root pathogens. This classification encompasses both conventional phenotypic observation and emerging genomic approaches that map resistance traits. Screening data informs breeding decisions, enabling the development of more robust cultivars suited to diverse cultivation environments. Understanding resistance profiles is critical for commercial and research breeding programs seeking stable, disease-tolerant genetics.

Breeders integrate disease resistance screening into parent selection and hybrid validation, using results to prioritize lines that reduce crop loss and chemical intervention. Systematic screening records support breeding program records and help establish cultivar stability claims based on observed phenotype rather than marketing assertion.